Drug Profile
PN 100
Alternative Names: Naproxen sodium/lansoprazole; PN-100Latest Information Update: 25 Jan 2008
Price :
$50
*
At a glance
- Originator POZEN
- Class Analgesics; Antipyretics; Antiulcers; Benzimidazoles; Gastric antisecretories; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Pyridines; Sulfoxides
- Mechanism of Action Cyclooxygenase inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis; Pain
Most Recent Events
- 25 Jan 2008 Discontinued - Phase-II for Osteoarthritis in USA (PO)
- 25 Jan 2008 Discontinued - Phase-II for Pain in USA (PO)
- 30 Mar 2006 PN 100 is available for licensing worldwide (http://www.pozen.com)